University of Missouri-Columbia Mar 31 2026 Follicular Lymphoma (FL) is a type of blood cancer and a form of non-Hodgkin's lymphoma. Thanks to new treatment breakthroughs, about 80% of FL patients have a survival rate of more than 10 years. The other 20%, however, experience a quickly recurring or a more aggressive version.  Researchers from the University of Missouri School of Medicine may have found a way to identify the patients at risk of recurrence, without the need for imaging and